{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"2770","value":"2880"},{"groupId":"OG001","spread":"3010","value":"3050"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"122"},{"groupId":"OG001","value":"77"}],"units":"Participants"}],"title":"Cycle 1 Day 1 (nominal Day 1)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19800","value":"49900"},{"groupId":"OG001","spread":"13600","value":"43400"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"52"}],"units":"Participants"}],"title":"Cycle 1 Day 8"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23000","value":"45300"},{"groupId":"OG001","spread":"20500","value":"50200"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"43"}],"units":"Participants"}],"title":"Cycle 1 Day 15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22400","value":"44000"},{"groupId":"OG001","spread":"23700","value":"48800"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"45"}],"units":"Participants"}],"title":"Cycle 1 Day 22"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24100","value":"40200"},{"groupId":"OG001","spread":"19400","value":"43800"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"107"},{"groupId":"OG001","value":"69"}],"units":"Participants"}],"title":"Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21700","value":"42400"},{"groupId":"OG001","spread":"21200","value":"44200"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"102"},{"groupId":"OG001","value":"68"}],"units":"Participants"}],"title":"Cycle 2 Day 15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21500","value":"46700"},{"groupId":"OG001","spread":"22000","value":"43700"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"100"},{"groupId":"OG001","value":"69"}],"units":"Participants"}],"title":"Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19300","value":"44800"},{"groupId":"OG001","spread":"20100","value":"47400"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"98"},{"groupId":"OG001","value":"68"}],"units":"Participants"}],"title":"Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18800","value":"43100"},{"groupId":"OG001","spread":"19400","value":"43700"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"92"},{"groupId":"OG001","value":"61"}],"units":"Participants"}],"title":"Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18900","value":"46000"},{"groupId":"OG001","spread":"22000","value":"42000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"62"}],"units":"Participants"}],"title":"Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20500","value":"42800"},{"groupId":"OG001","spread":"20500","value":"45200"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"86"},{"groupId":"OG001","value":"57"}],"units":"Participants"}],"title":"Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19900","value":"43600"},{"groupId":"OG001","spread":"18900","value":"42600"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"55"}],"units":"Participants"}],"title":"Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18400","value":"42900"},{"groupId":"OG001","spread":"17700","value":"43000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"51"}],"units":"Participants"}],"title":"Cycle 9 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19000","value":"41000"},{"groupId":"OG001","spread":"18500","value":"43900"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"29"}],"units":"Participants"}],"title":"Cycle 10 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15300","value":"45900"},{"groupId":"OG001","spread":"17600","value":"39700"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"35"}],"units":"Participants"}],"title":"Cycle 11 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15200","value":"43700"},{"groupId":"OG001","spread":"19800","value":"46600"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"26"}],"units":"Participants"}],"title":"Cycle 12 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17200","value":"44000"},{"groupId":"OG001","spread":"19900","value":"42600"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"26"}],"units":"Participants"}],"title":"Cycle 13 Day 1"}],"denoms":[{"counts":[{"groupId":"OG000","value":"149"},{"groupId":"OG001","value":"92"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Participants with completely resected Stage IIC, IIIA, or IIIB cutaneous melanoma) received vemurafenib, 960 mg twice daily, in 28-day cycles, for up to 52 weeks","id":"OG000","title":"Cohort 1 Vemurafenib"},{"description":"Participants with Stage IIIC cutaneous melanoma received vemurafenib, 960 mg twice daily, in 28-day cycles, for up to 52 weeks","id":"OG001","title":"Cohort 2 Vemurafenib"}],"paramType":"MEAN","populationDescription":"The pharmacokinetic (PK)-evaluable population included all participants who received at least one dose of vemurafenib and had provided valid PK assessments.","reportingStatus":"POSTED","timeFrame":"Pre-morning dose (0 hour [hr]) and 1 to 4 hrs post-dose on Days 1, 8, 15, and 22 of Cycle 1; pre-morning dose (0 hr) on Days 1 and 15 of Cycle 2; pre-morning dose (0 hr) on Day 1 of Cycles 3-13; at end of treatment (up to 13 months)","title":"Plasma Concentration of Vemurafenib","type":"SECONDARY","unitOfMeasure":"nanograms per milliliter (ng/mL)"}